Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4854 USD | +2.82% | -3.13% | -30.76% |
Mar. 21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
Mar. 14 | Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors | CI |
Financials (USD)
Sales 2022 | 1.68M | Sales 2023 | 1.93M | Capitalization | 822M |
---|---|---|---|---|---|
Net income 2022 | -105M | Net income 2023 | -62M | EV / Sales 2022 | 505 x |
Net Debt 2022 | 19.29M | Net Debt 2023 | 43.43M | EV / Sales 2023 | 448 x |
P/E ratio 2022 |
-7.59
x | P/E ratio 2023 |
-11.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.96% |
1 day | -1.67% | ||
1 week | -6.61% | ||
Current month | -9.04% | ||
1 month | -2.28% | ||
3 months | -22.86% | ||
6 months | -30.06% | ||
Current year | -32.65% |
Managers | Title | Age | Since |
---|---|---|---|
Linda F. Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Alton L. Boynton
FOU | Founder | 79 | 96-03-17 |
Marnix L. Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 99-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alton L. Boynton
FOU | Founder | 79 | 96-03-17 |
Linda F. Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Navid Malik
BRD | Director/Board Member | 55 | 12-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.4854 | +2.82% | 381 369 |
24-04-23 | 0.4721 | -1.67% | 1,867,962 |
24-04-22 | 0.4801 | +0.02% | 1,499,476 |
24-04-19 | 0.48 | -5.88% | 1,678,164 |
24-04-18 | 0.51 | +1.78% | 1,123,818 |
Delayed Quote OTC Markets, April 23, 2024 at 03:58 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-32.65% | 568M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.17% | 22.19B | |
-16.16% | 21.33B | |
-7.10% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- NWBO Stock